Non-Animal Softgel Capsules Market

Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.

Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.

Non-Animal Softgel Capsules Market contains market size and forecasts of Non-Animal Softgel Capsules in global, including the following market information:

Global Non-Animal Softgel Capsules Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Non-Animal Softgel Capsules Market Sales, 2017-2022, 2023-2028, (M Capsules)

Global top five Non-Animal Softgel Capsules companies in 2021 (%)

The global Non-Animal Softgel Capsules market was valued at 569 million in 2021 and is projected to reach US$ 907.2 million by 2028, at a CAGR of 6.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Plant Polysaccharides Softgel Capsules Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non-Animal Softgel Capsules include Catalent, Procaps Laboratorios, EuroCaps, Best Formulations, Aenova, Captek, Sirio, Bahrain Pharma and Robinson Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Non-Animal Softgel Capsules manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-Animal Softgel Capsules Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Capsules)

Global Non-Animal Softgel Capsules Market Segment Percentages, by Type, 2021 (%)

Plant Polysaccharides Softgel Capsules

Starch Softgel Capsules

Global Non-Animal Softgel Capsules Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Capsules)

Global Non-Animal Softgel Capsules Market Segment Percentages, by Application, 2021 (%)

Health Supplements

Pharmaceutical

Others

Global Non-Animal Softgel Capsules Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Capsules)

Global Non-Animal Softgel Capsules Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non-Animal Softgel Capsules revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Non-Animal Softgel Capsules revenues share in global market, 2021 (%)

Key companies Non-Animal Softgel Capsules sales in global market, 2017-2022 (Estimated), (M Capsules)

Key companies Non-Animal Softgel Capsules sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Catalent

Procaps Laboratorios

EuroCaps

Best Formulations

Aenova

Captek

Sirio

Bahrain Pharma

Robinson Pharma

Aland

Fuji Capsule

Sunsho Pharmaceutical

Erkang